Stem cell and precursor cell therapy

NeuroMolecular Medicine

Volumn 2, Issue 3, 2002, Pages 233-249

  Cai, Jingli ^a   Rao, Mahendra S ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Hematopoietic cells; Islet cells; Neural stem cells; Progenitor cells; Repair; Replacement; Stem cells; Transplantation

Indexed keywords

CALCIUM PHOSPHATE CERAMIC; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; APOPTOSIS; BONE GRAFT; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; ECTODERM; EMBRYO; EMBRYO CELL; ENDODERM; FETUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESODERM; NERVE CELL; NEURAL STEM CELL; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW; SKIN GRAFT; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SPECIFICITY; UMBILICAL CORD BLOOD; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; EMBRYO INDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ANIMALIA;

ANIMALS; CELL CULTURE TECHNIQUES; EMBRYONIC INDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 0042827436     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:2:3:233     Document Type: Review

References (120)

1. Cronkite E. P. and Feinendegen L. E. (1976). Notions about human stem cells. Nouv. Rev. Fr. Hematol. Blood Cells 17, 269-284.
2. Weissman I., Spangrude G., Heimfeld S., Smith L., and Uchida N. (1991). Stem cells. Nature 353, 26.
3. Kalyani A. J. and Rao M. S. (1998). Cell lineage in the developing neural tube. Biochem. Cell Biol. 76, 1051-1068.
4. Rao M. S. (1999). Multipotent and restricted precursors in the central nervous system. Anat. Rec. 257, 137-148.
5. Gage F. H. (2000). Mammalian neural stem cells. Science 287, 1433-1438.
6. Anderson D. J. (2001). Stem cells and pattern formation in the nevous system: the possible versus the actual. Neuron 30, 19-35.
7. Weissman I. L., Anderson D. J., and Gage F. (2001). Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17, 387-403.
8. Gage F. H. (2002). Neurogenesis in the adult brain. J. Neurosci. 22, 612-613.
9. Kohn D. B. (1999). Gene therapy using hematopoietic stem cells. Curr. Opin. Mol. Ther. 1, 437-442.
10. Craddock C. (2000). Haemopoietic stem cell transplantation: recent progress and future promise. Lancet Oncol. 1, 227-234.
11. Bordignon C. and Roncarolo M. G. (2002). Therapeutic applications for hematopoietic stem cell gene transfer. Nat. Immunol. 3, 318-321.
12. Emery D. W., Nishino T., Murata K., Fragkos M., and Stamatoyannopoulos G. (2002). Hematopoietic stem cell gene therapy. Int. J. Hematol. 75, 228-236.
13. Myers L. W. (2001). Immunologic therapy for secondary and primary progressive multiple sclerosis. Curr. Neurol. Neurosci. Rep. 1, 286-293.
14. Jansen J., Thompson J. M., Dugan M. J., et al. (2002). Peripheral blood progenitor cell transplantation. Ther. Apher. 6, 5-14.
15. Bhatia V. and Porter D. L. (2001). Novel approaches to allogeneic stem cell therapy. Expert Opin. Biol. Ther. 1, 3-15.
16. Horak D. A. and Forman S. J. (2001). Critical care of the hematopoietic stem cell patient. Crit. Care Clin. 17, 671-695.
17. Lagasse E., Shizuru, J. A., Uchida N., Tsukamoto A., and Weissman I. L. (2001). Toward regenerative medicine. Immunity 14, 425-436.
18. Hintzen R. Q. (2002). Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges. Mult. Scler. 8, 155-160.
19. Kozak T. and Rychlik I. (2002). Developments in hematopoietic stem cell transplantation in the treatment of autoimmune diseases. Isr. Med. Assoc. J. 4, 268-271.
20. Kondziolka D., Wechsler L., Goldstein S., et al. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569.
21. Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R., et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719.
22. Lindvall O. (2001). Parkinson disease. Stem cell transplantation. Lancet 358 Suppl, S48.
23. Check E. (2002). Parkinson's patients show positive response to implants. Nature 416, 666.
24. Shapiro A. M., Lakey J. R., Ryan E. A., Korbutt G. S., Toth E., Warnock G. L., et al. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238.
25. Soria B., Skoudy A., and Martin F. (2001). From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia. 44, 407-415.
26. Yang T. Y., Oh S. H., Jeong I. K., Seo I. A., Oh E. Y., Kim S. J., et al. (2002). First human trial of pancreatic islet allo-transplantation in Korea-focus on re-transplantation. Diabetes Res. Clin. Pract. 56, 107-113.
27. Thivolet C. (2001). New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies. Clin. Endocrinol. (Oxf) 55, 565-574.
28. Horwitz E. M., Prockop D. J., Gordon P. L., et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97, 1227-1231.
29. Boyan B. D., Lohmann C. H., Romero J., and Schwartz Z. (1999). Bone and cartilage tissue engineering. Clin. Plast. Surg. 26, 629-645, ix.
30. Freed L. E., Martin I., and Vunjak-Novakovic G. (1999). Frontiers in tissue engineering. In vitro modulation of chondrogenesis. Clin. Orthop. S46-58.
31. Bello Y. M., Falabella A. F., and Eaglstein W. H. (2001). Tissue-engineered skin. Current status in wound healing. Am. J. Clin. Dermatol. 2, 305-313.
32. Hardy C. L. and Tavassoli M. (1988). Homing of hemopoietic stem cells to hemopoietic stroma. Adv. Exp. Med. Biol. 241, 129-133.
33. Tavassoli M. and Hardy C. L. (1990). Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 76, 1059-1070.
34. Whetton A. D. and Graham G. J. (1999). Homing and mobilization in the stem cell niche. Trends Cell Biol. 9, 233-238.
35. Steindler D. A. and Pincus D. W. (2002). Stem cells and neuropoiesis in the adult human brain. Lancet 359, 1047-1054.
36. Taylor R. M. and Snyder E. Y. (1997). Widespread engraftment of neural progenitor and stem-like cells throughout the mouse brain. Transplant. Proc. 29, 845-847.
37. Ourednik V., Ourednik J., Flax J. D., Zawada W. M., Hutt C., Yang C., et al. (2001). Segregation of human neural stem cells in the developing primate forebrain. Science 293, 1820-1824.
38. Snyder E. Y. and Wolfe J. H. (1996). Central nervous system cell transplantation: a novel therapy for storage diseases? Curr. Opin. Neurol. 9, 126-136.
39. Aboody K. S., Brown A., Rainov N. G., et al. (2000). From the cover: neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA 97, 12,846-12,851.
40. Nishino H., Hida H., Takei N., Kumazaki M., Nakajima K., and Baba H. (2000). Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Exp. Neurol. 164, 209-214.
41. Cao Q. L., Zhang Y. P., Howard R. M., Walters W. M., Tsoulfas P., and Whittemore S. R. (2001). Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol. 167, 48-58.
42. Magnuson D. S., Zhang Y. P., Cao Q. L., Han Y., Burke D. A., and Whittemore S. R. (2001). Embryonic brain precursors transplanted into kainate lesioned rat spinal cord. Neuroreport 12, 1015-1019.
43. Fricker R. A., Carpenter M. K., Winkler C., Greco C., Gates M. A., and Bjorklund A. (1999). Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci. 19, 5990-6005.
44. Englund U., Fricker-Gates R. A., Lundberg C., Bjorklund A., and Wictorin K. (2002). Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentation with long-distance axonal projections. Exp. Neurol. 173, 1-21.
45. Svendsen C. N., Clarke D. J., Rosser A. E., and Dunnett S. B. (1996). Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp. Neurol. 137, 376-388.
46. Svendsen C. N. and Rosser A. E. (1995). Neurones from stem cells? Trends Neurosci. 18, 465-467.
47. Wichterle H., Garcia-Verdugo J. M., Herrera D. G., and Alvarez-Buylla A. (1999). Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nat. Neurosci. 2, 461-466.
48. Briscoe J., Pierani A., Jessell T. M., and Ericson J. (2000). A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 101, 435-445.
49. McCarthy M., Turnbull D. H., Walsh C. A., and Fishell G. (2001). Telencephalic neural progenitors appear to be restricted to regional and glial fates before the onset of neurogenesis. J. Neurosci. 21, 6772-6781.
50. Na E., McCarthy M., Neyt C., Lai E., and Fishell G. (1998). Telencephalic progenitors maintain anteroposterior identities cell autonomously. Curr. Biol. 8, 987-990.
51. Rubenstein J. L. (2000). Intrinsic and extrinsic control of cortical development. Novartis Found Symp. 228, 67-75; discussion 75-82, 109-113.
52. Young M. J., Ray J., Whiteley S. J., Klassen H., and Gage F. H. (2000). Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats. Mol. Cell. Neurosci. 16, 197-205.
53. Durbec P. and Rougon G. (2001). Transplantation of mammalian olfactory progenitors into chick hosts reveals migration and differentiation potentials dependent on cell commitment. Mol. Cell Neurosci. 17, 561-576.
54. Alison M., Golding M., Lalani el N., and Sarraf C. (1998). Wound healing in the liver with particular reference to stem cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 353, 877-894.
55. Caterson E. J., Nesti L. J., Albert T., Danielson K., and Tuan R. (2001). Application of mesenchymal stem cells in the regeneration of musculoskeletal tissues. Med. Gen. Med. E1.
56. Muschler G. F. and Midura R. J. (2002). Connective tissue progenitors: practical concepts for clinical applications. Clin. Orthop. 66-80.
57. Sheen V. L., Arnold M. W., Wang Y., and Macklis J. D. (1999). Neural precursor differentiation following transplantation into neocortex is dependent on intrinsic developmental state and receptor competence. Exp. Neurol. 158, 47-62.
58. Han S. S. and Fischer I. (2000). Neural stem cells and gene therapy: prospects for repairing the injured spinal cord. JAMA 283, 2300-2301.
59. Guha C., Deb N. J., Sappal B. S., Ghosh S. S., Roy-Chowdhury N., and Roy-Chowdhury J. (2001). Amplification of engrafted hepatocytes by preparative manipulation of the host liver. Artif. Organs 25, 522-528.
60. Laconi S., Pillai S., Porcu P. P., Shafritz D. A., Pani P., and Laconi E. (2001). Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am. J. Pathol. 158, 771-777.
61. Gordon G. J., Butz G. M., Grisham J. W., and Coleman W. B. (2002). Isolation, short-term culture, and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats. Transplantation 73, 1236-1243.
62. Sommer L. and Rao M. (2002). Neural stem cells and regulation of cell number. Prog. Neurobiol. 66, 1-18.
63. Chen J., Li Y., and Chopp M. (2000). Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39, 711-716.
64. Li Y., Chen J., Wang L., Lu M., and Chopp M. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666-1672.
65. Zhao L. R., Duan W. M., Reyes M., Keene C. D., Verfaillie C. M., and Low W. C. (2002). Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174, 11-20.
66. Flax J. D., Aurora S., Yang C., Simonin C., Wills A. M., Billinghurst L. L., et al. (1998). Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16, 1033-1039.
67. Ramon-Cueto A., Cordero M. I., Santos-Benito F. F., and Avila J. (2000). Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25, 425-435.
68. Boruch A. V., Conners J. J., Pipitone M., et al. (2001). Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia. 33, 225-229.
69. Lu J. and Ashwell K. (2002). Olfactory ensheathing cells: their potential use for repairing the injured spinal cord. Spine 27, 887-892.
70. McDonald J. W., Liu X. Z., Qu Y., Liu S., Mickey S. K., Turetsky D., et al. (1999). Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5, 1410-1412.
71. Akerud P., Canals J. M., Snyder E. Y., and Arenas E. (2001). Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21, 8108-8118.
72. Blakemore W. F., Crang A. J., and Curtis R. (1986). The interaction of Schwann cells with CNS axons in regions containing normal astrocytes. Acta. Neuropathol. (Berl) 71, 295-300.
73. Harvey A. R. and Plant G. W. (1995). Schwann cells and fetal tectal tissue cografted to the midbrain of newborn rats: fate of Schwann cells and their influence on host retinal innervation of grafts. Exp. Neurol. 134, 179-191.
74. Guest J. D., Rao A., Olson L., Bunge M. B., and Bunge R. P. (1997). The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp. Neurol. 148, 502-522.
75. Hayashi S. and Flake A. W. (2001). In utero hematopoietic stem cell therapy. Yonsei Med. J. 42, 615-629.
76. Hill L. M., Guzick D., Fries J., Hixson J., and Rivello D. (1990). The transverse cerebellar diameter in estimating gestational age in the large for gestational age fetus. Obstet. Gynecol. 75, 981-985.
77. Harrington K. and Campbell S. (1993). Fetal size and growth. Curr. Opin. Obstet. Gynecol. 5, 186-194.
78. Lysikiewicz A., Bracero L. A., and Tejani N. (2001). Sonographically estimated fetal weight percentile as a predictor of preterm delivery. J. Matern. Fetal. Med. 10, 44-47.
79. Agarwal S. K. and Fisk N. M. (2001). In utero therapy for lower urinary tract obstruction. Prenat. Diagn. 21, 970-976.
80. Stevens G. H., Schoot B. C., Smets M. J., et al. (2002). The ex utero intrapartum treatment (EXIT) procedure in fetal neck masses: a case report and review of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 100, 246-250.
81. Teng Y. D., Lavik E. B., Qu X., Park K. I., Ourednik J., Zurakowski D., et al. (2002). Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. USA 99, 3024-3029.
82. Park K. D., Kwon I. K., and Kim Y. H. (2000). Tissue engineering of urinary organs. Yonsei Med. J. 41, 780-788.
83. Fuchs J. R., Nasseri B. A., and Vacanti J. P. (2001). Tissue engineering: a 21st century solution to surgical reconstruction. Ann. Thorac. Surg. 72, 577-591.
84. Zandstra P. W. and Nagy A. (2001). Stem cell bioengineering. Annu. Rev. Biomed. Eng. 3, 275-305.
85. Yang E. K., Seo Y. K., Youn H. H., Lee D. H., Park S. N., and Park J. K. (2000). Tissue engineered artificial skin composed of dermis and epidermis. Artif. Organs 24, 7-17.
86. Kuroyanagi Y., Yamada N., Yamashita R., and Uchinuma E. (2001). Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif. Organs 25, 180-186.
87. Goble E. M., Kohn D., Verdonk R., and Kane S. M. (1999). Meniscal substitutes-human experience. Scand. J. Med. Sci. Sports 9, 146-157.
88. Pittenger M. F., Mosca J. D., and McIntosh K. R. (2000). Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr. Top. Microbiol. Immunol. 251, 3-11.
89. LeGeros R. Z. (2002). Properties of osteoconductive biomaterials: calcium phosphates. Clin. Orthop. 81-98.
90. Buckley M. J., Agarwal S., and Gassner R. (1999). Tissue engineering and dentistry. Clin. Plast. Surg. 26, 657-662, x.
91. Malament K. A. (2000). Prosthodontics: achieving quality esthetic dentistry and integrated comprehensive care. J. Am. Dent. Assoc. 131, 1742-1749.
92. Alessandri G., Girelli M., Taccagni G., Colombo A., Nicosia R., Caruso A., et al. (2001). Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab. Invest. 81, 875-885.
93. Nerem R. M. and Seliktar D. (2001). Vascular tissue engineering. Annu. Rev. Biomed. Eng. 3, 225-243.
94. Tiwari A., Salacinski H. J., Hamilton G., and Seifalian A. M. (2001). Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur. J. Vasc. Endovasc. Surg. 21, 193-201.
95. Ferber D. (1999). Tissue engineering. Growing human corneas in the lab. Science 286, 2051, 2053.
96. Griffith M., Osborne R., Munger R., Xiong X., Doillon C. J., Laycock N. L., et al. (1999). Functional human corneal equivalents constructed from cell lines. Science 286, 2169-2172.
97. Germain L., Carrier P., Auger F. A., Salesse C., and Guerin S. L. (2000). Can we produce a human corneal equivalent by tissue engineering? Prog. Retin. Eye Res. 19, 497-527.
98. Humayun M. S. (2001). Intraocular retinal prosthesis. Trans. Am. Ophthalmol. Soc. 99, 271-300.
99. Raine C. H. and Martin J. (2001). Cochlear and middle ear implants: advances for the hearing impaired. Hosp. Med. 62, 664-668.
100. Kerdraon Y. A., Downie J. A., Suaning G. J., et al. (2002). Development and surgical implantation of a vision prosthesis model into the ovine eye. Clin. Experiment. Ophthalmol. 30, 36-40.
101. Rauschecker J. P. and Shannon R. V. (2002). Sending sound to the brain. Science 295, 1025-1029.
102. Tuch B. E. and Beretov J. (1994). Interaction between xenografted human fetal pancreas and liver. Transplant. Proc. 26, 3333.
103. Angioi K., Hatier R., Merle M., and Duprez A. (2002). Xenografted human whole embryonic and fetal entoblastic organs develop and become functional adult-like micro-organs. J. Surg. Res. 102, 85-94.
104. Macchiarini P., Candelier J. J., Coullin P., et al. (2000). Use of embryonic human trachea grown in nude mice to patch-repair congenital tracheal stenosis. Transplantation 70, 1555-1559.
105. Zeltinger J., Landeen L. K., Alexander H. G., Kidd I. D., and Sibanda B. (2001). Development and characterization of tissue-engineered aortic valves. Tissue Eng. 7, 9-22.
106. Lou H. (1982). Developmental Neurology. Raven Press, p. 291.
107. Kambe N., Kambe M., Kochan J. P., and Schwartz L. B. (2001). Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97, 2045-2052.
108. Jessen K. R., Brennan A., Morgan L., Mirsky R., Kent A., Hashimoto Y., et al. (1994). The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron 12, 509-527.
109. Lehrer M. S., Sun T. T., and Lavker R. M. (1998). Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J. Cell Sci. 111 (Pt 19), 2867-2875.
110. Silver A. F., Chase H. B., and Potten C. S. (1969). Melanocyte precursor cells in the hair follicle germ during the dormat stage (telogen). Experientia. 25, 299-301.
111. Sell S. (2001). The role of progenitor cells in repair of liver injury and in liver transplantation. Wound Repair Regen. 9, 467-482.
112. Metcalf D. (1998). Pre-progenitor cells: a proposed new category of hematopoietic precursor cells. Leukemia 12, 1-3.
113. Al-Awqati Q. and Oliver J. A. (2002). Stem cells in the kidney. Kidney Int. 61, 387-395.
114. Van R. L. and Roncari D. A. (1982). Complete differentiation in vivo of implanted cultured adipocyte precursors from adult rats. Cell Tissue Res. 225, 557-566.
115. Yiou R., Dreyfus P., Chopin D. K., Abbou C. C., and Lefaucheur J. P. (2002). Muscle precursor cell autografting in a murine model of urethral sphincter injury. BJU Int. 89, 298-302.
116. Fang J. and Hall B. K. (1997). Chondrogenic cell differentiation from membrane bone periostea. Anat. Embryol. (Berl) 196, 349-362.
117. Long M. W., Robinson J. A., Ashcraft E. A., and Mann K. G. (1995). Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J. Clin. Invest. 95, 881-887.
118. Akeson A. L., Wetzel B., Thompson F. Y., et al. (2000). Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev. Dyn. 217, 11-23.
119. Oka T., Hayashi K., Nakaoka Y., Ohtsuki Y., and Akagi T. (2000). Differentiation of rat thymic myoid progenitor cell line established by coculture with human T-lymphotropic virus type-I producing human T cells. Cell Tissue Res. 300, 119-127.
120. Alpert S., Hanahan D., and Teitelman G. (1988). Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53, 295-308.